TWM
CRL icon

Thrive Wealth Management’s Charles River Laboratories CRL Stock Holding History

Thrive Wealth Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,140
Closed -$225K – 203
2024
Q3 		$225K Buy
1,140
+38
+3% +$7.9K 0.04% 202
2024
Q2 		$228K Buy
1,102
+26
+2% +$5.89K 0.04% 191
2024
Q1 		$292K Buy
1,076
+110
+11% +$26.3K 0.06% 161
2023
Q4 		$228K Buy
+966
New +$190K 0.05% 171
2023
Q3 		– Sell
-1,000
Closed -$210K – 171
2023
Q2 		$210K Buy
+1,000
New +$199K 0.05% 171
2023
Q1 		– Sell
-956
Closed -$208K – 172
2022
Q4 		$208K Buy
+956
New +$209K 0.06% 152

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return